I would agree if this wasn't at 35c already. Now maybe people don't read the financials and don't read the sales of the companies they are suing, and instead just jump into this one blind, that might happen, who knows, but with 200MM fully diluted, that gives this a market cap of $70MM right now. I really don't see these lawsuits getting them much more than $100MM total, so it's already at 70% of what they can win, that's already too high, not much more room to go. Plus there are other plays out there, maybe not all in pre-markman, but pre-markman isn't the only play, you have post-markman, pre-trial, post-trial, all those are possible buy in points based on current valuation. This market is just like bio plays, many hurdles to get through and POSSIBLE buying opportunities, based on price, at each stage. At this stage this one is a sell, after a markman win and a damages report this might be a buy again depending on where the price is.IMO
"You take the blue pill – the story ends, you wake up in your bed and believe whatever you want to believe. You take the red pill – you stay in Wonderland and I show you how deep the rabbit-hole goes." -Morpheus
